Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SCIENCE GROUP PLC Regulatory Filings 2021

Jun 30, 2021

7903_dva_2021-06-30_97209535-827a-4929-a930-982ac47e7321.html

Regulatory Filings

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 2036D

Science Group PLC

30 June 2021

30 June 2021

Science Group plc

(the "Company" or "Science Group")

Total voting rights

The Company's total issued share capital (excluding treasuring shares) consists of 41,239,726 shares of 1 penny each.  Science Group holds 822,309 shares in treasury.  Of the total issued share capital, 104,400 shares are held by the Frontier Smart Technologies Employee Benefit Trust and hence the total number of voting rights in the Company is therefore 41,135,326.

The figure of 41,135,326 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure and Transparency Rules.

- Ends -

For further information:

Science Group plc
Sarah Cole, Company Secretary Tel: +44 (0) 1223 875 200
www.sciencegroup.com
Stifel Nicolaus Europe Limited (Nominated Adviser and Joint Broker)
Nick Adams, Alex Price Tel: +44 (0) 20 7710 7600
Liberum Capital Limited (Joint Broker)
Neil Patel, Cameron Duncan Tel: +44 (0) 20 3100 2000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TVRBXGDLBDDDGBU